These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11755120)
21. Synthesis and SAR of 5-amino- and 5-(aminomethyl)benzofuran histamine H3 receptor antagonists with improved potency. Sun M; Zhao C; Gfesser GA; Thiffault C; Miller TR; Marsh K; Wetter J; Curtis M; Faghih R; Esbenshade TA; Hancock AA; Cowart M J Med Chem; 2005 Oct; 48(20):6482-90. PubMed ID: 16190774 [TBL] [Abstract][Full Text] [Related]
22. Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis. Joshi UM; Rao P; Kodavanti S; Lockard VG; Mehendale HM Biochim Biophys Acta; 1989 Aug; 1004(3):309-20. PubMed ID: 2758025 [TBL] [Abstract][Full Text] [Related]
23. Induction of CYP3A by 2,3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytes. Shenoy SD; Spencer TA; Mercer-Haines NA; Abdolalipour M; Wurster WL; Runge-Morris M; Kocarek TA Mol Pharmacol; 2004 May; 65(5):1302-12. PubMed ID: 15102959 [TBL] [Abstract][Full Text] [Related]
24. A cell-based assay using HepaRG cells for predicting drug-induced phospholipidosis. Tomida T; Ishimura M; Iwaki M J Toxicol Sci; 2017; 42(5):641-650. PubMed ID: 28904299 [TBL] [Abstract][Full Text] [Related]
25. Adaptation of an in vitro phospholipidosis assay to an automated image analysis system. Schurdak ME; Vernetti LA; Abel SJ; Thiffault C Toxicol Mech Methods; 2007; 17(2):77-86. PubMed ID: 20020975 [TBL] [Abstract][Full Text] [Related]
26. In vitro assays and biomarkers for drug-induced phospholipidosis. Monteith DK; Morgan RE; Halstead B Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):687-96. PubMed ID: 17014389 [TBL] [Abstract][Full Text] [Related]
27. Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations in the rat. Sgaragli GP; Della Corte L; Gremigni D Pharmacol Res Commun; 1983 Mar; 15(3):231-46. PubMed ID: 6856656 [TBL] [Abstract][Full Text] [Related]
28. Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes. Ogimura E; Tokizono M; Sekine S; Nakagawa T; Bando K; Ito K J Pharm Sci; 2017 Sep; 106(9):2509-2514. PubMed ID: 28465153 [TBL] [Abstract][Full Text] [Related]
29. Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration. Yudate HT; Kai T; Aoki M; Minowa Y; Yamada T; Kimura T; Ono A; Yamada H; Ohno Y; Urushidani T Toxicology; 2012 May; 295(1-3):1-7. PubMed ID: 22426296 [TBL] [Abstract][Full Text] [Related]
31. Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk. Okamoto H; Hamaguchi R; Kuroda Y J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():33-40. PubMed ID: 28285021 [TBL] [Abstract][Full Text] [Related]
32. Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids. Takagi M; Sanoh S; Santoh M; Ejiri Y; Kotake Y; Ohta S J Toxicol Sci; 2016 Feb; 41(1):155-64. PubMed ID: 26763403 [TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518. Crul M; Beerepoot LV; Stokvis E; Vermaat JS; Rosing H; Beijnen JH; Voest EE; Schellens JH Cancer Chemother Pharmacol; 2002 Dec; 50(6):473-8. PubMed ID: 12451474 [TBL] [Abstract][Full Text] [Related]
34. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development. Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938 [TBL] [Abstract][Full Text] [Related]
35. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis. van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975 [TBL] [Abstract][Full Text] [Related]